🫀🧬 Cardio-Oncology: where modern cancer cures meet the heart
As cancer survival improves, cardiovascular toxicity has emerged as a defining challenge of our time. From BTK inhibitor–associated atrial fibrillation ⚡, to immune checkpoint inhibitor myocarditis 🔥, to VEGF-driven hypertension 🩸, the heart increasingly pays the price of precision oncology.
This FAQ-driven, clinician-ready Cardio-Oncology resource, grounded in the 2025 ACC Concise Clinical Guidance published in the Journal of the American College of Cardiology (JACC), translates complexity into clarity—highlighting permissive cardiotoxicity, multidisciplinary care 🤝, and practical decision-making that protects both survival and the heart ❤️.
Because in modern medicine, we should never have to choose between curing cancer and caring for the heart.
